Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Hoflehner, Elisabeth ^a   Hufnagl, Karin ^a   Schabussova, Irma ^a   Jasinska, Joanna ^a   Hoffmann Sommergruber, Karin ^a   Bohle, Barbara ^a   Maizels, Rick M ^b   Wiedermann, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; BIRCH POLLEN EXTRACT; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN EXTRACT; RECOMBINANT ALLERGEN; RECOMBINANT API G 1 ALLERGEN; RECOMBINANT API G 1 BET V 1 DAU C 1 ALLERGEN; RECOMBINANT BET V 1 ALLERGEN; RECOMBINANT DAU C 1 ALLERGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BASOPHIL DEGRANULATION; BIRCH; BIRCH POLLEN; CARROT; CELERY; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITOPE MAPPING; FEMALE; FOOD ALLERGY; GENETIC ENGINEERING; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; MUCOSAL ADMINISTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLLEN; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE; TH2 CELL;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, PLANT; BASOPHILS; BETULA; CELL DEGRANULATION; CYTOKINES; EPITOPES; FEMALE; FOOD HYPERSENSITIVITY; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; NASAL MUCOSA; POLLEN; RECOMBINANT PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

APIUM GRAVEOLENS VAR. DULCE; DAUCUS CAROTA; MUS;

EID: 84863110393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039409     Document Type: Article

References (33)

1. Bohle B, (2007) The impact of pollen-related food allergens on pollen allergy. Allergy 62: 3-10.
2. Bucher X, Pichler WJ, Dahinden CA, Helbling A, (2004) Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 59: 1272-1276.
3. Hoffmann-Sommergruber K, (2000) Plant allergens and pathogenesis-related proteins. What do they have in common? Int Arch Allergy Immunol 122: 155-166.
4. Steinman H, (2009) Oral allergy syndrome- whats new? Current Allergy & Clinical Immunology 22.
5. Geroldinger-Simic M, Zelniker T, Aberer W, Ebner C, Egger C, et al. (2011) Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol 127: 616-622 e611.
6. Hansen KS, Khinchi MS, Skov PS, Bindslev-Jensen C, Poulsen LK, et al. (2004) Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res 48: 441-448.
7. Mauro M, Russello M, Incorvaia C, Gazzola G, Frati F, et al. (2011) Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol 156: 416-422.
8. Wild C, Wallner M, Hufnagl K, Fuchs H, Hoffmann-Sommergruber K, et al. (2007) A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities. Allergy 62: 33-41.
9. Winkler B, Hufnagl K, Spittler A, Ploder M, Kallay E, et al. (2006) The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Allergy 61: 173-180.
10. Hufnagl K, Winkler B, Focke M, Valenta R, Scheiner O, et al. (2005) Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J Allergy Clin Immunol 116: 370-376.
11. Bublin M, Radauer C, Wilson IB, Kraft D, Scheiner O, et al. (2003) Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. Faseb J 17: 1697-1699.
12. Wiedermann U, Jahn-Schmid B, Bohle B, Repa A, Renz H, et al. (1999) Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J Allergy Clin Immunol 103: 1202-1210.
13. Hufnagl K, Wagner B, Winkler B, Baier K, Hochreiter R, et al. (2003) Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice. Clin Exp Immunol 133: 170-176.
14. Leech MD, Benson RA, De Vries A, Fitch PM, Howie SE, (2007) Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+ regulatory cells. J Immunol 179: 7050-7058.
15. Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, et al. (2005) Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202: 1199-1212.
16. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ, (2008) 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 180: 5211-5221.
17. Wiedermann U, Herz U, Baier K, Vrtala S, Neuhaus-Steinmetz U, et al. (2001) Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol 126: 68-77.
18. Asanuma H, Thompson AH, Iwasaki T, Sato Y, Inaba Y, et al. (1997) Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 202: 123-131.
19. Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, et al. (2007) Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610.
20. Winkler B, Baier K, Wagner S, Repa A, Eichler HG, et al. (2002) Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy 32: 30-36.
21. Hufnagl K, Focke M, Gruber F, Hufnagl P, Loupal G, et al. (2008) Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides. Clin Exp Allergy 38: 1192-1202.
22. Jahn-Schmid B, Radakovics A, Luttkopf D, Scheurer S, Vieths S, et al. (2005) Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol 116: 213-219.
23. Asero R, (1998) Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 28: 1368-1373.
24. Walker SM, Durham SR, Till SJ, Roberts G, Corrigan CJ, et al. (2011) Immunotherapy for allergic rhinitis. Clin Exp Allergy 41: 1177-1200.
25. Bohle B, Radakovics A, Jahn-Schmid B, Hoffmann-Sommergruber K, Fischer GF, et al. (2003) Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level. Eur J Immunol 33: 3303-3310.
26. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, et al. (2006) Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61: 151-165.
27. Pilette C, Nouri-Aria KT, Jacobson MR, Wilcock LK, Detry B, et al. (2007) Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol 178: 4658-4666.
28. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, et al. (1989) Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 170: 1415-1420.
29. Coffman RL, Lebman DA, Shrader B, (1989) Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 170: 1039-1044.
30. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT, (2008) Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 121: 1467-1472, 1472 e1461.
31. Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, et al. (2010) Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 40: 598-606.
32. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, et al. (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33: 1205-1214.
33. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, et al. (2006) Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117: 176-183.